COVID-19 and STEMI
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
The COVID-19 pandemic had an unexpected impact on cardiovascular emergencies, particularly STEMI. The France PCI registry and other studies around the world have highlighted a significant decrease in myocardial infarctions arriving at hospital. This decrease is mainly related to patients' fear of coming to the hospital and being contaminated. Although the STEMI revascularisation time targets (<120min) are often difficult to achieve in normal times, they were almost impossible to achieve in periods of lockdown because of the many obstacles. Longer delays and longer total ischemic time have led to excess mortality, especially in the regions most affected by the epidemic. Recommendations for the management of STEMI during the COVID-19 period have thus been issued by the scientific societies. STEMI in patients with COVID-19 often have an uncommon clinical presentation, and the absence of coronary obstruction on angiography is frequent. Their prognosis is very poor. Only public information campaigns and an organisation adapted to the management of coronary emergencies during epidemics can try to limit their effects and avoid aggravating an already fragile health situation in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Annales de cardiologie et d'angeiologie - 69(2020), 6 vom: 15. Dez., Seite 355-359 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
COVID-19 et SCA ST |
|---|
| Beteiligte Personen: |
Hakim, R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ancard.2020.09.034 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31638819X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31638819X | ||
| 003 | DE-627 | ||
| 005 | 20231225160956.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.ancard.2020.09.034 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM31638819X | ||
| 035 | |a (NLM)33069381 | ||
| 035 | |a (PII)S0003-3928(20)30143-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Hakim, R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 and STEMI |
| 246 | 3 | 3 | |a COVID-19 et SCA ST |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a The COVID-19 pandemic had an unexpected impact on cardiovascular emergencies, particularly STEMI. The France PCI registry and other studies around the world have highlighted a significant decrease in myocardial infarctions arriving at hospital. This decrease is mainly related to patients' fear of coming to the hospital and being contaminated. Although the STEMI revascularisation time targets (<120min) are often difficult to achieve in normal times, they were almost impossible to achieve in periods of lockdown because of the many obstacles. Longer delays and longer total ischemic time have led to excess mortality, especially in the regions most affected by the epidemic. Recommendations for the management of STEMI during the COVID-19 period have thus been issued by the scientific societies. STEMI in patients with COVID-19 often have an uncommon clinical presentation, and the absence of coronary obstruction on angiography is frequent. Their prognosis is very poor. Only public information campaigns and an organisation adapted to the management of coronary emergencies during epidemics can try to limit their effects and avoid aggravating an already fragile health situation in the future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Confinement | |
| 650 | 4 | |a Infarctus du myocarde | |
| 650 | 4 | |a Lockdown | |
| 650 | 4 | |a Myocardial infarction | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Pandémie | |
| 650 | 4 | |a SCA ST+ | |
| 650 | 4 | |a STEMI | |
| 700 | 1 | |a Motreff, P |e verfasserin |4 aut | |
| 700 | 1 | |a Rangé, G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de cardiologie et d'angeiologie |d 1968 |g 69(2020), 6 vom: 15. Dez., Seite 355-359 |w (DE-627)NLM000057096 |x 1768-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2020 |g number:6 |g day:15 |g month:12 |g pages:355-359 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ancard.2020.09.034 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2020 |e 6 |b 15 |c 12 |h 355-359 | ||